Clinical Trials Logo

Clinical Trial Summary

OCT is an optical technology that emerged as a non-invasive skin imaging for the skin. In this protocol, the investigators plan to study the optical imaging features of leukoderma. An estimated 65 subjects will be included in this trial. This is an observational, non-randomised, non-controlled, prospective cohort study to observe the feasibility of in vivo OCT as a image tool in the diagnosis of leukoderma. Use of the device will not affect the clinical management of the subjects. Scientific Aim: To evaluate the feasibility ApolloVue S100 image system as a tool in the differential diagnosis of leukoderma..


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04935424
Study type Observational
Source Chang Gung Memorial Hospital
Contact
Status Completed
Phase
Start date August 3, 2021
Completion date December 31, 2022